Anti-Villin antibody [SM5212] (STJA0005212)

SKU:
STJA0005212

€213.13 - €291.88
Shipping:
Free Shipping
Current Stock:
Host: Mouse
Applications: WB/IHC/IF
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Villin is suitable for use in Western Blot, Immunohistochemistry and Immunofluorescence research applications.
Clonality: Monoclonal
Clone ID: SM5212
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% sodium azide, 100 Mu g/ml BSA and 50% glycerol.
Purification: Affinity purification
Dilution Range: WB (H, M, R) 1:500-1:1000
IHC/IF (H, M, R) 1:500-1:2000/1:500-1:1000
Storage Instruction: Store at-20C for up to one year, and avoid repeated freeze-thaw cycles.
Gene Symbol: Vil1
Gene ID: 22349
Uniprot ID: VILI_MOUSE
Immunogen: Recombinant protein corresponding to Mouse Villin
Post Translational Modifications Phosphorylated on tyrosine residues by SRC. The unphosphorylated form increases the initial rate of actin-nucleating activity, whereas the tyrosine phosphorylated form inhibits actin-nucleating activity, enhances actin-bundling activity and enhances actin-severing activity by reducing high Ca(2+) requirements. The tyrosine phosphorylated form does not regulate actin-capping activity. Tyrosine phosphorylation is essential for cell migration: tyrosine phosphorylation sites in the N-terminus half regulate actin reorganization and cell morphology, whereas tyrosine phosphorylation sites in the C-terminus half regulate cell migration via interaction with PLCG1. Tyrosine phosphorylation is induced by epidermal growth factor (EGF) and stimulates cell migration.
Function Epithelial cell-specific Ca(2+)-regulated actin-modifying protein that modulates the reorganization of microvillar actin filaments. Plays a role in the actin nucleation, actin filament bundle assembly, actin filament capping and severing. Binds phosphatidylinositol 4,5-bisphosphate (PIP2) and lysophosphatidic acid (LPA).binds LPA with higher affinity than PIP2. Binding to LPA increases its phosphorylation by SRC and inhibits all actin-modifying activities. Binding to PIP2 inhibits actin-capping and -severing activities but enhances actin-bundling activity. Regulates the intestinal epithelial cell morphology, cell invasion, cell migration and apoptosis. Protects against apoptosis induced by dextran sodium sulfate (DSS) in the gastrointestinal epithelium. Appears to regulate cell death by maintaining mitochondrial integrity. Enhances hepatocyte growth factor (HGF)-induced epithelial cell motility, chemotaxis and wound repair. Upon S.flexneri cell infection, its actin-severing activity enhances actin-based motility of the bacteria and plays a role during the dissemination.
Protein Name Villin-1
Cellular Localisation Cytoplasm
Cytoskeleton
Cell Projection
Microvillus
Lamellipodium
Ruffle
Filopodium Tip
Filopodium
Rapidly Redistributed To Ruffles And Lamellipodia Structures In Response To Autotaxin
Lysophosphatidic Acid (Lpa) And Epidermal Growth Factor (Egf) Treatment
Relocalized In The Tip Of Cellular Protrusions And Filipodial Extensions Upon Infection With S
Flexneri In Primary Intestinal Epithelial Cells (Iec) And In The Tail-Like Structures Forming The Actin Comets Of S
Flexneri
Redistributed To The Leading Edge Of Hepatocyte Growth Factor (Hgf)-Induced Lamellipodia
Alternative Antibody Names Anti-Villin-1 antibody
Anti-Vil1 antibody
Anti-Vil antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance